CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 221 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,170,147 | +23.6% | 189,765 | +1.0% | 0.00% | +33.3% |
| Q2 2023 | $4,182,221 | -7.7% | 187,965 | -10.1% | 0.00% | 0.0% |
| Q1 2023 | $4,530,514 | -4.2% | 209,165 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $4,727,457 | -18.7% | 232,765 | +2.6% | 0.00% | -25.0% |
| Q3 2022 | $5,814,000 | +8.8% | 226,765 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $5,343,000 | -8.5% | 224,665 | -13.4% | 0.00% | +33.3% |
| Q1 2022 | $5,841,000 | +21.5% | 259,365 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $4,809,000 | -0.5% | 242,865 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $4,835,000 | -10.5% | 245,700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,405,000 | -9.9% | 245,700 | -2.6% | 0.00% | -25.0% |
| Q1 2021 | $6,000,000 | -7.6% | 252,200 | +1.6% | 0.00% | -20.0% |
| Q4 2020 | $6,493,000 | +51.1% | 248,200 | +0.6% | 0.01% | +66.7% |
| Q3 2020 | $4,296,000 | +5.1% | 246,800 | +1.5% | 0.00% | 0.0% |
| Q2 2020 | $4,089,000 | +72.4% | 243,100 | +21.9% | 0.00% | 0.0% |
| Q1 2020 | $2,372,000 | +0.1% | 199,500 | +1.8% | 0.00% | +50.0% |
| Q4 2019 | $2,370,000 | -13.5% | 195,900 | +1.0% | 0.00% | -33.3% |
| Q3 2019 | $2,741,000 | +28.0% | 193,900 | +0.9% | 0.00% | +50.0% |
| Q2 2019 | $2,142,000 | -3.7% | 192,100 | +1.4% | 0.00% | 0.0% |
| Q1 2019 | $2,224,000 | -9.9% | 189,400 | +2.5% | 0.00% | -33.3% |
| Q4 2018 | $2,468,000 | -1.6% | 184,700 | +3.2% | 0.00% | 0.0% |
| Q3 2018 | $2,508,000 | -10.8% | 178,900 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,812,000 | +15.2% | 178,900 | +20.6% | 0.00% | 0.0% |
| Q1 2018 | $2,440,000 | -5.6% | 148,300 | +3.6% | 0.00% | 0.0% |
| Q4 2017 | $2,586,000 | -3.4% | 143,200 | +3.2% | 0.00% | 0.0% |
| Q3 2017 | $2,677,000 | +63.5% | 138,700 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $1,637,000 | +16.5% | 138,700 | +8.2% | 0.00% | 0.0% |
| Q1 2017 | $1,405,000 | +50.9% | 128,200 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $931,000 | +11.8% | 128,200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $833,000 | +19.0% | 128,200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $700,000 | +40.0% | 128,200 | +16.0% | 0.00% | 0.0% |
| Q1 2016 | $500,000 | +10.6% | 110,500 | +21.8% | 0.00% | 0.0% |
| Q4 2015 | $452,000 | +32.6% | 90,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $341,000 | -25.9% | 90,700 | +18.6% | 0.00% | 0.0% |
| Q2 2015 | $460,000 | +196.8% | 76,500 | -21.6% | 0.00% | 0.0% |
| Q3 2013 | $155,000 | -8.3% | 97,600 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $169,000 | – | 97,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |